Literature DB >> 8533767

Fine mapping and haplotype analysis of the locus for congenital nephrotic syndrome on chromosome 19q13.1.

M Männikkö1, M Kestailä, C Holmberg, R Norio, M Ryynänen, A Olsen, L Peltonen, K Tryggvason.   

Abstract

We have recently localized the gene for congenital nephrotic syndrome of the Finnish type (CNF) to chromosome 19q12-13.1. On the basis of observed recombination events, the gene was localized between markers D19S416/D19S425/D19S213/D19S208/D19S191 and D19S224. Here we have extended the mapping efforts, on the basis of a detailed physical map of the region. By means of three new polymorphic markers--D19S608, D19S609, and D19S610--developed in this study, the critical candidate region could be further restricted. Significant linkage disequilibrium was observed with markers D19S610, D19S608, D19S224, and D19S220, the strongest allelic association being 84% with marker D19S610 at 19q13.1. This suggests that the CNF gene locus lies in close proximity to marker D19S610. Combination of the informative markers revealed four main haplotype categories. Different geographic distribution was observed between these haplotype groups when they were placed on the map of finland according to the birthplaces of grandparents.

Entities:  

Mesh:

Year:  1995        PMID: 8533767      PMCID: PMC1801413     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  32 in total

1.  Mapping of the gene encoding the alpha-subunit of the human H+,K(+)-ATPase to chromosome 19q13.1 by fluorescent in situ hybridization.

Authors:  I Song; T Yamada; J M Trent
Journal:  Genomics       Date:  1992-10       Impact factor: 5.736

2.  Dinucleotide repeat polymorphism at the D19S191 locus.

Authors:  D E Iles; B Segers; P de Jong; J Alleman; B Wieringa
Journal:  Nucleic Acids Res       Date:  1992-03-11       Impact factor: 16.971

3.  Assignment of the gene coding for human cytochrome c oxidase subunit VIb to chromosome 19, band q13.1, by fluorescence in situ hybridisation.

Authors:  J W Taanman; A Y van der Veen; C Schrage; H de Vries; C H Buys
Journal:  Hum Genet       Date:  1991-07       Impact factor: 4.132

4.  Characterization of (CA)n microsatellites with degenerate sequencing primers.

Authors:  D L Browne; M Litt
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

5.  Renal transplantation in small children with congenital nephrotic syndrome of the Finnish type.

Authors:  C Holmberg; H Jalanko; O Koskimies; M Leijala; K Salmela; B Eklund; J Ahonen
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

6.  Molecular cloning of human myelin-associated glycoprotein.

Authors:  G Spagnol; M Williams; J Srinivasan; J Golier; D Bauer; R V Lebo; N Latov
Journal:  J Neurosci Res       Date:  1989-10       Impact factor: 4.164

7.  Human cytochrome c oxidase subunit VIb: characterization and mapping of a multigene family.

Authors:  R D Carrero-Valenzuela; F Quan; R Lightowlers; N G Kennaway; M Litt; M Forte
Journal:  Gene       Date:  1991-06-30       Impact factor: 3.688

8.  Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor.

Authors:  W Wasco; K Bupp; M Magendantz; J F Gusella; R E Tanzi; F Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

9.  Cloning of the H,K-ATPase beta subunit. Tissue-specific expression, chromosomal assignment, and relationship to Na,K-ATPase beta subunits.

Authors:  V A Canfield; C T Okamoto; D Chow; J Dorfman; P Gros; J G Forte; R Levenson
Journal:  J Biol Chem       Date:  1990-11-15       Impact factor: 5.157

Review 10.  Management of congenital nephrotic syndrome of the Finnish type.

Authors:  C Holmberg; M Antikainen; K Rönnholm; M Ala Houhala; H Jalanko
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

View more
  8 in total

1.  Elevated frequency and allelic heterogeneity of congenital nephrotic syndrome, Finnish type, in the old order Mennonites.

Authors:  S Bolk; E G Puffenberger; J Hudson; D H Morton; A Chakravarti
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

Review 2.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

3.  Progressive myoclonus epilepsy EPM1 locus maps to a 175-kb interval in distal 21q.

Authors:  K Virtaneva; J Miao; A L Träskelin; N Stone; J A Warrington; J Weissenbach; R M Myers; D R Cox; P Sistonen; A de la Chapelle
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

4.  Assignment of the locus for PLO-SL, a frontal-lobe dementia with bone cysts, to 19q13.

Authors:  P Pekkarinen; I Hovatta; P Hakola; O Järvi; M Kestilä; U Lenkkeri; R Adolfsson; G Holmgren; P O Nylander; L Tranebjaerg; J D Terwilliger; J Lönnqvist; L Peltonen
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

5.  Improved prognosis for congenital nephrotic syndrome of the Finnish type in Irish families.

Authors:  J M Savage; J A Jefferson; A P Maxwell; A E Hughes; J H Shanks; D Gill
Journal:  Arch Dis Child       Date:  1999-05       Impact factor: 3.791

6.  The contribution of ultrasound for the differential diagnosis of congenital and infantile nephrotic syndrome.

Authors:  Hanna Salame; Nash Damry; Katt Vandenhoudt; Michèle Hall; Fred E Avni
Journal:  Eur Radiol       Date:  2003-05-08       Impact factor: 5.315

7.  Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations.

Authors:  U Lenkkeri; M Männikkö; P McCready; J Lamerdin; O Gribouval; P M Niaudet; K Antignac C; C E Kashtan; C Homberg; A Olsen; M Kestilä; K Tryggvason
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

8.  Molecular and genetic basis of inherited nephrotic syndrome.

Authors:  Maddalena Gigante; Matteo Piemontese; Loreto Gesualdo; Achille Iolascon; Filippo Aucella
Journal:  Int J Nephrol       Date:  2011-09-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.